Latest news

12th February 2018

MetaboGen is granted US diabetes patent

MetaboGen AB has on January 30th, 2018 been granted a US patent for the identification of a person at risk for developing type 2 diabetes (...) Read the full story

Contact us

MetaboGen AB

AZ BioVentureHub, HE424
c/o AstraZeneca R&D Mölndal
431 83 Mölndal

Visiting Address

Erik Dahlbergsgatan 11A
412 96 Göteborg
Sweden

Name *
Company *
E-mail *
Phone
Message *
Fields marked with * are mandatory.

Latest news

12th February 2018

MetaboGen is granted US diabetes patent

MetaboGen AB has on January 30th, 2018 been granted a US patent for the identification of a person at risk for developing type 2 diabetes (...) Read the full story

  • Metabogen
    Technology

    MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

  • Pharmaceutical
    Industry

    By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development.

  • Next Generation
    Probiotics

    Thorough investigation of the microbiome and identification of bacterial strains provides the probiotic industry with new tools for more precise product development.